• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

National Grain and Feed Association

Transforming America's Harvest

  • Sign In
  • News
    • NGFA Blog
    • Newsletter Archive (members only)
    • Press Releases
    • Podcast
  • Issues
    • Feed
    • Safety
    • Trade
    • Farm Bill
    • Transportation
    • Barge Digital Transformation (BDT) Project
  • Events
    • Calendar of Events
    • Convention
    • Country Elevator Conference & Trade Show
    • CONVEY
    • FSMA Courses
    • Trade Rules Seminar
  • Training
  • Advocacy
  • Arbitration
    • Arbitration Overview
    • Decisions
    • File a Complaint
    • Volunteer
  • Trade Rules
    • Trade Rules Overview
    • Trade Rules Committee
    • Order Rules Booklet
  • About
    • Officers and Staff
    • Committees
    • Strategic Alliances
    • State/Regional Affiliate Associations
  • Membership
    • Join the NGFA
    • Benefits & Services
    • Get Involved
    • Member Companies
    • Membership Directory (members only)
    • Committee Apprentice Program
  • Foundation

12.18.20 Feed, Newsletter

FDA releases 2019 annual summary report on animal antimicrobials sold or distributed

By David Fairfield, Senior Vice President, Feed

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA/CVM) on Dec. 15 published its 2019 summary report that recaps domestic sales and distribution of medically important antimicrobials approved for use in food-producing animals.

The Animal Drug User Fee Amendments of 2008 (ADUFA) requires that animal drug companies annually report to FDA the amount of antimicrobial drugs they sell or distribute for use in food-producing animals. ADUFA also requires FDA to issue annual summary reports of these sales and distribution data, which the agency has done since 2009.

The 2019 report indicates that domestic sales and distribution of medically important antimicrobials increased by three percent between 2018 and 2019. Further, the report shows that 2019 levels are down 25 percent since 2010 and down 36 percent since 2015, which was the peak year of sales. FDA states this trend demonstrates that on-going efforts to support judicious use of medically important antimicrobials – including transitioning the use of such drugs to require veterinary oversight – are having a positive impact. 

When reviewing the report’s information, FDA states the following should be considered:

  • Sales and distribution information does not represent actual use of the products. 
  • Before making a direct comparison between the quantity of antimicrobial drugs sold for use in humans and those sold for use in animals, be mindful: 1) there are many more animals in the United States than humans; 2) there are differences in physiology and weight between humans and animals; and 3) different animal species metabolize drugs differently, meaning that some may require more of the drug to be effective, or may need to be treated for a longer time.
  • The agency cautions against making direct comparisons of species-specific sales estimates, since there are a variety of factors that confound direct comparison of species-specific sales estimates. 
  • The agency cautions against making direct comparisons between the sales volume of different drug classes because not all drug classes are approved for use in all species, not all drug potencies are the same, and not all of the drug classes can be used interchangeably to treat the same conditions.

Related to judicious use of animal drugs, FDA/CVM on Sept. 14 released its five-year action plan that outlines steps the agency intends to take to further foster antimicrobial stewardship in veterinary settings.

sidebar

Blog Sidebar

Topics

  • Arbitration Decision (692)
    • Corn (6)
    • Rail (3)
    • Soybeans (2)
    • Truck (1)
    • Wheat (3)
  • Board Reports (33)
  • Issue Advisory (18)
  • Newsletter (1,807)
  • Press Releases (269)
  • Subject-focused News (1,735)
    • Agriculture Policy (258)
    • Arbitration (35)
    • Biotechnology (104)
    • Education and Training (40)
    • Event News (217)
    • Feed (291)
    • Foundation (9)
    • NGFA (91)
    • Risk Management (131)
    • Safety, Health & Environment (196)
    • Trade (250)
    • Transportation (312)
  • Uncategorized (23)

Footer

National Grain and Feed Association

TwitterYoutubeFacebookLinkedin

Contact Us

ngfa@ngfa.org
1400 Crystal Drive, Suite 260
Arlington, VA 22202
202.289.0873

Member Login

Have an account? → Log in 
Need an account? → Register
Lost your account? → Reset

Manage Your Account

Copyright ©  2023 NGFA | All Rights Reserved
  • Sign in

Forgot your password?

Lost your password? Please enter your email address. You will receive mail with link to set new password.

Back to login

Lacy Holleman
Manager of Legal Affairs and Arbitration

lholleman@ngfa.org

Lacy provides staff support for one of NGFA’s premier member services – its more than century old system of industry trade rules and arbitration that facilitates the efficient marketing of grains, oilseeds and their derived products. She also works on contracting, legal and other related matters.

An Arkansas native, Lacy received her undergraduate degree with a double major in history and Russian studies from the University of Tulsa (Okla.) and her law degree from Wake Forest University in Winston-Salem, N.C. Prior to joining NGFA’s staff in November 2020, she managed a local business at the Pentagon and completed mediation training required by the North Carolina Supreme Court for those seeking to serve as mediators for settlement conferences and other settlement procedures in North Carolina Superior Court civil actions. She also has worked as an assistant for a law firm in her native state.